Co-Receptors Required: CD4 (for MHC II) & CD8 (for MHC I)
Reference: Figure 4.25 (Janeway’s Immunobiology)
Peptides Presented by Class I Molecules Are Derived from Intracellular Protein Degradation
Proteasome degrades proteins
MHC locus genes LMP2 (β1i) & LMP7 (β5i) encode immunoproteasome subunits
Cytokine-inducible → produces peptides optimal for MHC I binding
Reference: Figure 7-13B
Peptide Transport into the ER by TAP-1 and TAP-2
TAP1/2 genes are within the MHC locus
Prefer peptides of 8-16 amino acids with hydrophobic/basic C-terminal residues
Reference: Figures 7-14B, 7-15
Role of MHC Class I in Viral Infections
Viral infections upregulate TAP1, TAP2, LMP2, LMP7 → enhances antigen presentation
Viruses encode MHC I pathway inhibitors (e.g., Herpes Virus ICP47)
MHC Class I: Expressed by all nucleated cells
MHC Class II: Expressed by specialized antigen-presenting cells (APCs)
Reference: Figure 4.27 (Janeway’s Immunobiology)
MHC II-Expressing Cells (APCs)
Dendritic cells, macrophages, and B cells constitutively express MHC II & provide costimulatory signals
Thymic epithelial cells play a role in T cell development
MHC Class II Molecules Bind Peptides of Various Lengths
Peptides: 13-18 amino acids (can be longer)
"Anchor residues" stabilize binding
References: Figures 4.20, 4.21 (Janeway’s Immunobiology)
Peptide Loading Process for MHC Class II
Peptides come from exogenous proteins
Dendritic cells can phagocytose exogenous antigens & present them on MHC I
Activates CD8+ T cells → Cross-Presentation
Flesh-Eating Disease, Toxic Shock Syndrome
Caused by Staphylococcus & Streptococcus
Superantigens (SEA, SEB enterotoxins) induce excessive immune activation